MedTrace Logo

Long-Term Follow Up of VOY-101 Non-nAMD Extension Study

NCT07660640 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2026-06-22

No results posted yet for this study

Summary

Long-Term Follow Up Extension for participants previously enrolled in a VOY-101 study for Advanced Non-Neovascular Age-Related Macular Degeneration

Conditions

  • Age-Related Macular Degeneration (AMD)
  • Non-Neovascular Age-Related Macular Degeneration

Interventions

OTHER

observational study

No intervention - observational study

BIOLOGICAL

VOY-101

One-time intravitreal injection of VOY-101.

Sponsors & Collaborators

  • Perceive Biotherapeutics, Inc.

    lead INDUSTRY

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-03
Primary Completion
2031-07-30
Completion
2031-08-30
FDA Drug
Yes

Countries

  • United States
  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07660640 on ClinicalTrials.gov